Market Overview

Wright Medical Group, BioMimetic Therapeutics Agree to Combine Businesses

Related WMGI
Events for the Week of Sept. 2-5th
Hospira Inc. (HSP) Jumps: Stock Adds 8.3% in Session - Tale of the Tape

Wright Medical Group (NASDAQ: WMGI) and BioMimetic Therapeutics,
(NASDAQ: BMTI) announced today that they have entered into a
definitive agreement for a business combination of Wright and
BioMimetic, both publicly traded, Tennessee-based companies. Wright is
an orthopedics company with a market-leading lower extremities
franchise. BioMimetic is focused on developing regenerative medicine
products to promote the healing of musculoskeletal injuries and diseases
with a novel protein therapeutic product, Augment® Bone
Graft, under late stage FDA review as a replacement for autologous bone
graft in foot and ankle fusions. The transaction will combine
BioMimetic's breakthrough biologics platform and pipeline with Wright's
established sales force and product portfolio, to further accelerate
growth opportunities in

See full press release

Posted-In: News Guidance Contracts Management Global

 

Related Articles (BMTI + WMGI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters